Skip to content

Nevirapine treatment linked to poorer cognitive development in children with HIV

Image by Elizabeth Glaser Pediatric AIDS Foundation/DFID - UK Department for International Development. Creative Commons licence. Image is for illustrative purposes only.

Long-term Canadian study shows HIV-exposed children have worse health outcomes

wavebreakmedia/Shutterstock.com

Rate of neural tube defects is no higher on dolutegravir

Andrey_Popov/Shutterstock.com

New data suggest PrEP in pregnancy is safe

Laurén Gómez at AIDS 2022. Photo by Rosalie Hayes.

HIV-exposed children experience subtle delays in acquiring language and motor skills, review finds

Evolving Communications/The Global Financing Facility. Creative Commons licence. Image is for illustrative purposes only.

Top 5 stories on HIV treatment and care in Africa from CROI 2022

Maya Jackson-Gibson presenting the study on COVID-19 and adverse birth outcomes at CROI 2022.

Infant weight and height lower with efavirenz than with dolutegravir in pregnancy

Dr Lynda Stranix-Chibanda (bottom right) at CROI 2022.

South African children with well-controlled HIV have lower bone mass compared to HIV-negative children

Image by Elizabeth Glaser Pediatric AIDS Foundation/DFID - UK Department for International Development. Creative Commons licence. Image is for illustrative purposes only.

Development of children of HIV-positive mothers continues to be impaired, says Zimbabwe study

Image by Elizabeth Glaser Pediatric AIDS Foundation/DFID - UK Department for International Development. Creative Commons licence. Image is for illustrative purposes only.